Celularity Inc — Director's Dealing 2024

Feb 22, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2024-02-16

Reporting Person: Hariri Robert J (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-16	Stock Option Grant (Right to Buy)	$0.4340	A	2937788	Acquired	2034-02-15	Class A Common Stock (2937788)	Direct

Footnotes

F1: The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date.